G2E-52318-44204
5 vaccinations
7 coded responses
53 check-ins
7 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 937 / CA
- Registered
- 2021-01-13
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-13
Registered in v-safe
-
2021-01-13
Dose 1 — Pfizer-BioNTech
- 2021-01-14
- 2021-01-16
-
2021-01-17
Survey response — days 1–6 daily, dose 1MedDRA: Neuralgia — Feeling: GoodFree text: Spot Neuralgias on & offMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-18
- 2021-01-19
- 2021-01-21
- 2021-01-27
- 2021-02-03
-
2021-02-17
Dose 2 — Pfizer-BioNTech
- 2021-02-17
- 2021-02-18
- 2021-02-19
- 2021-02-20
- 2021-02-21
- 2021-02-22
- 2021-02-23
- 2021-02-24
- 2021-03-03
- 2021-03-11
- 2021-03-17
- 2021-03-24
- 2021-03-31
- 2021-05-22
- 2021-08-18
-
2021-09-18
Dose 3 — Pfizer-BioNTech
- 2021-09-18
- 2021-09-19
- 2021-09-20
- 2021-09-21
- 2021-09-22
- 2021-09-23
- 2021-09-24
- 2021-09-25
-
2021-10-02
Survey response — day 14, dose 3MedDRA: Herpes simplex — Feeling: GoodFree text: Herpes simplex lesion under my left nostril.Possibly due to exposure to a rhinovirus?Any exposure to an active virus can trigger my HS 1.MedDRA releases: 2024-11 · check-in free text available
- 2021-10-09
- 2021-10-16
-
2021-10-23
Survey response — day 35, dose 3MedDRA: Diarrhoea, Fatigue, Headache, Nausea — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Nausea, headache, diarrhea, tiredMedDRA releases: 2024-11 · check-in free text available
- 2021-10-30
- 2021-12-18
-
2022-03-19
Survey response — 6 months, dose 3MedDRA: Chills, Fatigue, Headache, Pyrexia — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Fever, chills, exhaustion, headacheMedDRA releases: 2024-11 · check-in free text available
-
2022-03-19
Report sent to call center — 6 months, dose 3Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-03-22
-
2022-03-22
Call successfulNot applicable - Accidental Reporting
-
2022-04-14
Dose 4 — Pfizer-BioNTech
- 2022-04-14
- 2022-04-15
- 2022-04-16
- 2022-04-17
- 2022-04-18
-
2022-04-19
Survey response — days 1–6 daily, dose 4MedDRA: Spinal disorder — Feeling: Fair · Muscle or body aches, Fatigue or tiredness, NauseaFree text: Spine issues not related to COVIDMedDRA releases: 2024-11 · check-in free text available
- 2022-04-20
- 2022-04-21
- 2022-04-28
- 2022-05-05
- 2022-05-12
-
2022-05-19
Survey response — day 35, dose 4MedDRA: Body temperature increased, Cough, Diarrhoea, Headache, Nausea, Neuralgia, Oropharyngeal pain — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Liquid diarrhea, nausea, severe neuralgia pain, cough, low grade fever (98.9), headache, sore throat.MedDRA releases: 2024-11 · check-in free text available
- 2022-05-26
-
2022-07-14
Survey response — 3 months, dose 4MedDRA: Psychotherapy, Psychotic disorder, Spinal disorder — Feeling: Fair · Get care from a doctor or other healthcare professionalFree text: Symptoms: Lumbar spine & psych. problems · Healthcare visit (other): MRI, CT, epidural injections, psychotherapyMedDRA releases: 2024-11 · check-in free text available
-
2022-07-14
Report sent to call center — 3 months, dose 4Get care from a doctor or other healthcare professional1 call case(s)
- 2022-07-15
-
2022-07-15
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2022-09-16
Dose 5 — Pfizer-BioNTech
- 2022-10-13
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-13 | Pfizer-BioNTech | |
| 2 | 2021-02-17 | Pfizer-BioNTech | |
| 3 | 2021-09-18 | Pfizer-BioNTech | No |
| 4 | 2022-04-14 | Pfizer-BioNTech | No |
| 5 | 2022-09-16 | Pfizer-BioNTech | No |
Call center
2 call center cases
2 successful
Free text
Release 2 — days 1–6 daily, dose 1
Systemic reaction (other): Spot Neuralgias on & off
Release 9 — day 14, dose 3
Symptoms: Herpes simplex lesion under my left nostril.Possibly due to exposure to a rhinovirus?Any exposure to an active virus can trigger my HS 1.
Release 10 — day 35, dose 3
Symptoms: Nausea, headache, diarrhea, tired
Release 11 — 6 months, dose 3
Symptoms: Fever, chills, exhaustion, headache
Release 11 — days 1–6 daily, dose 4
Systemic reaction (other): Spine issues not related to COVID
Release 11 — day 35, dose 4
Symptoms: Liquid diarrhea, nausea, severe neuralgia pain, cough, low grade fever (98.9), headache, sore throat.
Release 12 — 3 months, dose 4
Symptoms: Lumbar spine & psych. problems
Healthcare visit (other): MRI, CT, epidural injections, psychotherapy
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Psychotherapy | · | · | ✓ |
| SD | Body temperature increased | · | · | ✓ |
| SD | Chills | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Diarrhoea | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Herpes simplex | · | · | ✓ |
| SD | Nausea | · | · | ✓ |
| SD | Neuralgia | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Psychotic disorder | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Spinal disorder | · | · | ✓ |
| SRO | Neuralgia | ✓ | ✓ | ✓ |
| SRO | Spinal disorder | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release